- Summary
- Price Reports
- Price History
- Add To Your Stocklist
- View your Stocklist
- Basic Chart
- Interactive Chart
- Headlines
- Company Snapshot
- Summary Reports
- Free Annual Report
- Estimate Snapshot
- Estimate Report
- Mobile Quote
- Real-Time Quote
- Streaming Quote
|
Amgen | Company Snapshot
-
![]()
-
-
-
Vol:
-
Last Trade:
|
AMGEN INC.
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
|
|
| Symbol: |
AMGN |
| Exchange(s): |
Nasdaq Stock Market |
| Industry: |
Consumer Products (Biotechnology & Pharmaceuticals) |
| 5-Star Rating: |
 |
|
ANNUAL FINANCIALS
|
|
|
Dec 31, 2008
12 Months
us$
|
Dec 31, 2007
12 Months
us$
|
Dec 31, 2006
12 Months
us$
|
3Yr.
Growth
% Change
|
|
Total Revenue ($000):
|
15,003,000
|
14,771,000
|
14,268,000
|
6.47
|
|
Earnings before Interest & Tax ($000):
|
5,566,000
|
4,289,000
|
4,149,000
|
3.87
|
|
Profit/Loss ($000):
|
4,196,000
|
3,166,000
|
2,950,000
|
4.53
|
|
Earnings per Share:
|
3.92
|
2.83
|
2.51
|
9.69
|
|
Total Assets ($000):
|
36,443,000
|
34,639,000
|
33,788,000
|
7.55
|
|
Dividends Per Share
|
0.00
|
0.00
|
0.00
|
|
|
Return on Com. Equity:
|
21.94
|
17.19
|
14.97
|
|
|
Employees:
|
N/A
|
N/A
|
N/A
|
|
|
|
|
|
Trailing 12 Month Results
|
|
|
12 Months ended
Sep 30, 2009,us$
|
12 Months ended
Sep 30, 2008,us$
|
%Change
|
|
Total Revenue ($000):
|
14,584,000
|
14,997,000
|
-2.75
|
|
Profit/Loss ($000):
|
4,635,000
|
4,070,000
|
13.88
|
|
Earnings per Share:
|
4.51
|
3.78
|
19.31
|
|
Dividends Per Share
|
0.00
|
0.00
|
|
Number of Shares:
|
1,015,480,000
|
1,058,040,000
|
|
|
|
|
COMPANY INFORMATION
|
| Incorporation: |
United States |
| |
| Securities: |
AMGN-Q
|
|
| |
|
|
| |
|
|
Financial data is provided by Zacks Investment Research.
| |
All information on this site is compiled by CTVglobemedia Publishing Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, CTVglobemedia Publishing Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor.
Copyright © 2009 CTVglobemedia Publishing Inc. All rights reserved.
|
|
|
